Table 3. Antifungal susceptibility patterns of Candida species to different antifungal drugs.
Antifungal | Species (n=130) | ||||
---|---|---|---|---|---|
C. albicans (n=109) | C. glabrata (n=11) | C. tropicalis (n=8) | C. dubliniensis (n=2) | P | |
Fluconazole | 0.277 | ||||
S | 102 (93.6%) | 9 (81.8%) | 6 (75%) | 2 (100%) | |
I | 2 (1.8%) | ||||
R | 5 (4.6%) | 2 (18.2%) | 2 (25%) | ||
Voriconazole | 0.061 | ||||
S | 105 (96.3%) | 9 (81.8%) | 6 (75%) | 2 (100%) | |
I | 1 (0.9%) | ||||
R | 3 (2.8%) | 2 (18.2%) | 2 (25%) | ||
Caspofungin | 0.065 | ||||
S | 105 (96.3%) | 9 (81.8%) | 6 (75%) | 2 (100%) | |
R | 4 (3.7%) | 2 (18.2%) | 2 (25%) | ||
Micafungin | 0.068 | ||||
S | 105 (96.3%) | 9 (81.8%) | 6 (75%) | 2 (100%) | |
R | 4 (3.7%) | 2 (18.2%) | 2 (25%) | ||
Amphotericin B | 0.068 | ||||
S | 105 (96.3%) | 9 (81.8%) | 6 (75%) | 2 (100%) | |
R | 4 (3.7%) | 2 (18.2%) | 2 (25%) | ||
Flucytosine | 0.0934 | ||||
S | 102 (93.6%) | 10 (90.9%) | 7 (87.5%) | 2 (100%) | |
I | 2 (1.8%) | ||||
R | 5 (4.6%) | 1 (9.1%) | 1 (12.5%) |
S: susceptible; I: intermediate; R: resistant. P<0.05 (chi-square test).